Gimme Care review
One of the simpler price lists for compounded semaglutide and tirzepatide, with a month-to-month option and no membership fee. The catch: it sells compounded drugs only, and it takes no insurance, Medicare or Medicaid.
Research-based review: nobody from GLPLens signed up, paid or received medication. Everything below comes from Gimme Care's own pages and FDA, read Sep 27, 2026. How we score.
60 / 100
- What it prescribes
- 10 / 40 Compounded versions only
- Published prices
- 20 / 20 Membership and medication prices published
- Commitment
- 20 / 20 Cancel anytime
- Insurance
- 0 / 10 Self-pay only
- Where it operates
- 10 / 10 All 50 states
Website: gimme.care. We do not link to it: it sells compounded GLP-1s. Brand-name options: the price table.
Good
- Short, clear price list on the home page
- Month-to-month plan and a cheaper 3-month plan
- No membership fee
- Says it serves all 50 states and DC
Watch out for
- Compounded drugs only, no FDA-approved brand-name option
- Plans renew automatically unless you cancel
- No insurance, Medicare or Medicaid
- Orders cannot be cancelled once dispensed or shipped
What it is
Gimme Care is a cash-pay telehealth service for compounded semaglutide and compounded tirzepatide, with a short price list and a month-to-month plan. The company behind it is Start Gimme LLC [1]. It also sells non-GLP-1 products such as NAD+, sermorelin and an anti-nausea drug.
What it prescribes
Compounded drugs only. Gimme Care’s own footer says its products are compounded medicines made by licensed compounding pharmacies [2]. It also says they are not FDA-approved and have not been through clinical trials for safety, efficacy or equivalence to approved drugs [3]. FDA’s general warning says the same about compounded drugs [14].
That footer is plain about the limits, which helps readers. It also means there is no Wegovy or Zepbound here. See our Wegovy and Zepbound pages for approved options.
What it costs
The price list sits on the home page. There are two plans for each drug.
| Plan | Compounded semaglutide | Compounded tirzepatide |
|---|---|---|
| Month to month | $160 a month [5] | $199 a month [4] |
| 3 months, billed every 3 months | $130 a month [5] | $163 a month [4] |
Gimme Care says the price covers the drug, physician care, support, shipping and supplies, with no membership fee [6].
It does not take commercial insurance and is not enrolled in Medicare or Medicaid [7]. For brand-name cash prices, see GLP-1 costs without insurance.
Where it operates
Gimme Care says it serves all 50 states and DC [8]. In five states (Kansas, Louisiana, Mississippi, New Mexico and West Virginia) you need a short video or audio visit before starting [9].
Signing up and cancelling
Plans are subscriptions unless checkout says otherwise [10]. Refills ship every 28 days after a short check-in [11]. You can manage or cancel the subscription in the patient portal [12]. An order can be cancelled only before the pharmacy dispenses or ships it [13]. Our guide to cancelling a GLP-1 program explains what to check.
Safety and regulatory record
A search of FDA’s warning letter database for Gimme Care, Start Gimme and its web address returned no warning letter when this page was updated. Gimme Care does not name its pharmacies on the pages reviewed here, so we could not check them. Its products remain compounded drugs that FDA has not approved [14].
Who it suits, and who should look elsewhere
Gimme Care suits a cash buyer who has chosen a compounded drug with a prescriber and wants a low, simple price with a month-to-month option. Look elsewhere if you want an FDA-approved medicine, if you have Medicare, Medicaid or a plan that might cover a brand-name drug (see our coverage guide), or if you want to know which pharmacy makes your medicine before you sign up. Our programs page lists other options.
Sources
Start Gimme LLC (Gimme Care). All rights reserved.
gimme.care, read Sep 27, 2026.The products offered by Gimme Care are compounded medications prepared by licensed compounding pharmacies.
gimme.care, read Sep 27, 2026.These formulations are not approved by the U.S. Food and Drug Administration (FDA) and have not undergone clinical trials to evaluate their safety, efficacy, or therapeutic equivalence to any FDA-approved medications.
gimme.care, read Sep 27, 2026.Compounded tirzepatide Billing cycle Per month 1 month $ 199 3 month $ 163
gimme.care, read Sep 27, 2026.Compounded semaglutide Billing cycle Per month 1 month $ 160 3 month $ 130
gimme.care, read Sep 27, 2026.$130 per month with a 3-month plan (billed every 3 months), or $160 per month with a month-to-month plan. Price includes medication, physician care, support, shipping, and all supplies. No hidden fees or membership costs.
gimme.care, read Sep 27, 2026.Start Gimme (Gimme Care) and the Providers do not accept commercial health insurance plans, are not in-network with any commercial health insurance plans, and are not enrolled with federal or state health care programs, such as Medicare and Medicaid.
gimme.care, read Sep 27, 2026.Gimme is proud to offer its services in all 50-states and the District of Columbia.
gimme.care, read Sep 27, 2026.In Kansas, Louisiana, Mississippi, New Mexico, and West Virginia, a brief video or audio visit is required before starting treatment.
gimme.care, read Sep 27, 2026.Products and services are subscription-based unless stated otherwise at checkout.
gimme.care, read Sep 27, 2026.Shipped every 28 days after a short check-in, track and monitor via the online portal
gimme.care, read Sep 27, 2026.Subscription details and cancellation options are available anytime in your patient portal.
gimme.care, read Sep 27, 2026.You can cancel your order anytime before it's dispensed or shipped by the pharmacy. Once your order has been dispensed or shipped, it can't be canceled.
gimme.care, read Sep 27, 2026.However, compounded drugs are not FDA approved. This means the agency does not review compounded drugs for safety, effectiveness or quality before they are marketed.
fda.gov, read Sep 27, 2026.
Other reviews: all programs, scored the same way. Real users' experiences: reader stories.